Skip to main content
. 2023 Jul 29;79(10):1333–1339. doi: 10.1007/s00228-023-03544-x

Table 3.

Evaluated non-osteoporotic treatments that patients received

AA 1
AI 40
Anastrozole 19
Letrozole 12
Exemestane 9
PPI 113
SSRI 58
Benzodiazepines 97
GnRH agonists 2
Thyroid hormones 98
Oral corticosteroids 41
≤ 5 mg/day 10
> 5 mg/day 31
Inhaled corticosteroids 17
≤ 1000 µg/day 16
> 1000 µg/day 1
Thiazides 42
Statins 153

AA antiandrogens, AI aromatase inhibitors, PPI proton pump inhibitors, SSRI selective serotonin reuptake inhibitors, GnRH gonadotropin-releasing hormone